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Abstract
Recently, silver nanoparticles (AgNPs) have been shown to provide a novel approach to overcome tumors, especially
those of hepatocarcinoma. However, the anticancer mechanism of silver nanoparticles is unclear. Thus, the purpose of
this study was to estimate the effect of AgNPs on proliferation and activation of ROS-mediated signaling pathway on
human hepatocellular carcinoma HePG-2 cells. A simple chemical method for preparing AgNPs with superior anticancer
activity has been showed in this study. AgNPs were detected by transmission electronic microscopy (TEM) and energy
dispersive X-ray (EDX). The size distribution and zeta potential of silver nanoparticles were detected by Zetasizer Nano.
The average size of AgNPs (2 nm) observably increased the cellular uptake by endocytosis. AgNPs markedly inhibited the
proliferation of HePG-2 cells through induction of apoptosis with caspase-3 activation and PARP cleavage. AgNPs with
dose-dependent manner significantly increased the apoptotic cell population (sub-G1). Furthermore, AgNP-induced
apoptosis was found dependent on the overproduction of reactive oxygen species (ROS) and affecting of MAPKs and
AKT signaling and DNA damage-mediated p53 phosphorylation to advance HePG-2 cells apoptosis. Therefore, our
results show that the mechanism of ROS-mediated signaling pathways may provide useful information in AgNP-induced
HePG-2 cell apoptosis.
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Background
As one of the most common type of liver cancer, hepato-
cellular carcinoma (HCC) is the third cause of malignant
deaths from cancer-associated worldwide [1–3]. Unfortu-
nately, the diagnosis of HCC is difficult in its earliest
stages without screening tests available [4]. Meanwhile,
owing to its poor sensitivity to chemotherapeutic agents,
high metastatic potential, and resistance to traditional
drugs, it is dismal to the overall prognosis of patients with
HCC. Thus, it is imperative to develop efficient chemo-
therapy that has become the great challenge in clinical
treatment [5, 6]. In addition, most of current anticancer
agents usually have short half-life in the blood circulation
and poor aqueous solubility, which hampers therapeutic
efficacy of chemotherapy [7, 8]. Recently, nanomaterials
have been widely used in biomedical field due to its
unique physicochemical properties, including their size
distribution, stability of dispersion, morphology, crys-
talline structure, and thermal properties, that might
have the potential to overcome these problems [9]. The
increased of application of nanomaterials resulted in
raising hopes for employing nanoparticles as alternative
anticancer agents [10, 11].
Silver nanoparticles (AgNPs) are less toxic than other
form of silver that has obtained an easy access to cells
and tissues [12, 13]. AgNPs attract considerable public
attention in consumer and medical products compared
to other metal materials for their excellent surface en-
hanced Raman scattering and unique antimicrobial ac-
tivities [14–17]. Silver nanoparticles have been used
widely as antibacterial agents in food storage and envir-
onmental [18–21]. Furthermore, AgNPs exhibit low tox-
icity in humans and have diverse in vitro and in vivo
application [22–24]. Moreover, AgNPs have also been
shown to combine with corona virus and restrain to
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bind host cells [25]. Thus, exposure to silver nanoparti-
cles as a promising anticancer silver species is becoming
increasing intimate and widespread.
Reactive oxygen species (ROS) encompasses highly
reactive molecules, including superoxide anion radical,
oxygen free radicals, hydroxyl radical, hydrogen perox-
ide, and singlet oxygen [26]. As a marked imbalance,
oxidative stress is the most often described between
cellular defense mechanisms and consumption of ROS
[27]. The ROS play an important role in many physio-
logical processes. The redox imbalance is associated
with many pathologies, such as skin disease, diabetes, can-
cer, Leigh syndrome, and other diseases [28]. Although
many research groups describe the toxicity of AgNP
induction of oxidative stress, little is known about the
anticancer mechanisms of AgNPs [29]. It is of great inter-
est to ascertain this mechanism of AgNPs. This study was
to determine how AgNP-associated changes in redox
balance will induce HePG-2 cells apoptosis.
Methods
Materials
HePG-2 cells were purchased from American Type
Culture Collection (ATCC, Manassas, Virginia). Fetal
bovine serum (FBS) and Dulbecco’s modified Eagle’s
medium (DMEM) were purchased from Gibco. AKT,
p53, PARP, and cleaved caspase-3 antibody were ob-
tained from Cell Signaling Technology. Silver nitrate
(AgNO3) and vitamin C (VC) were obtained from Sigma.
Thiazolyl blue tetrazolium bromide (MTT), 4′6-diami-
dino-2-phenyindole (DAPI), 2′,7′-dichlorofluorescein dia-
cetate (DCF-DA), bicinchoninic acid (BCA), 6-coumarin,
and propidium iodide (PI) were obtained from Sigma.
LysoTracker Deep Red was obtained from Invitrogen. The
water was supplied by Milli-Q water purification from
Millipore in all experiments.
Synthesis of AgNPs
A stock solution of AgNO3 (400 μg/ml) was prepared by
dissolving 16 mg AgNO3 powder in 40 ml Milli-Q water.
Vitamin C (400 μg/ml) was also prepared by dissolving
16 mg vitamin C in 40 ml Milli-Q water. AgNPs were
prepared as follows: briefly, 0.1 ml of 400 μg/ml vitamin
C was drop by drop added into 4 ml of 400 μg/ml
AgNO3 under magnetic stirring for 2 h. The excess VC
and AgNO3 were eliminated by dialysis against Milli-Q
water for 24 h. The solution containing nanoparticles
was sonicated (KQ-100VDB) by using a water bath for
2 min and pass through filters of 0.2-μm pore size before
each experiment. The AgNP concentration was detected
by ICP-AES (inductively coupled plasma-atomic emission
spectrometry).
Characterization of AgNPs
The morphology of silver nanoparticles was characterized
by transmission electron microscope (TEM, Hitachi, H-
7650). The size distribution and zeta potential of AgNPs
were detected through Zetasizer Nano ZS (Malvern In-
struments Limited) particle analyzer. EDX analysis was
carried out on an EX-250 system (Horiba) and employed
to examine the elemental composition of AgNPs.
Cell Viability Assay
HePG-2 cells were incubated in DMEM supplemented with
antibiotic and 10 % FBS, penicillin, and streptomycin in a
humidified incubator with 5 % CO2 atmosphere at 37 °C.
The cytotoxicity of AgNPs was detected by MTT assay as
previously published [30]. Briefly, cell viability was deter-
mined by measuring the ability of cells to transform MTT
to a purple formazan dye. HePG-2 cells were seeded in 96-
well culture plates at a density of 4 × 104 cells per well at
37 °C for 24 h. Then, the cells were treated with AgNPs at
different concentrations for 72 h. After treatment, 20 μl/
well of MTT solution (5 mg/ml in PBS) was added and
incubated for another 5 h. The medium was removed and
replaced with 150 μl/well DMSO to dissolve the formazan
crystals. The color intensity of the formazan solution, which
reflects the cell viability, was measured at 570 nm using a
microplate spectrophotometer (Versammax). The number
of test repetitions was three times.
Intracellular Trafficking of AgNPs
To determine the in vitro cellular uptake of AgNPs, the
nanoparticles containing a fluorescent dye 6-coumarin
were added to the reaction system. The incorporated dye
as a probe for AgNPs offers a sensitive method to deter-
mine their intracellular localization. The localization of 6-
coumarin-labeled 5 μg/ml AgNPs in HePG-2 cells was
monitored by DAPI and Lyso Tracker as before [31]. The
treated cells cultured in 2-cm cell culture dishes to 70 %
confluence were incubated with Lyso Tracker Red (stained
for 2 h), and DAPI H33258 was added (stained for
30 min). The cells were rinsed with PBS three times and
then incubated with 6-coumarin-loaded AgNPs from 0 to
120 min which were detected by fluorescence microscope.
Flow Cytometric Analysis
Flow cytometric was used to characterize the effect of
AgNPs on cell cycle distribution as previously reported
[32, 33]. Briefly, the cells incubated with AgNPs for 24 h
were collected and centrifuged at 1500 rpm for 5 min.
The harvested cells were fixed with pre-cooled 70 %
ethanol at −20 °C for 24 h. Cells were followed by PI
staining for half an hour in the dark. Apoptotic cells
with hypodiploid DNA content were measured by using
Multicycle software.
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Fig. 1 Structural characterization of AgNPs. a TEM image of AgNPs. b EDX analysis of AgNPs. c Size distribution of AgNPs. d Zeta potential of AgNPs
Fig. 2 6-coumarin-labeled AgNPs in HePG-2 cells. The HePG-2 cells were treated with 6-coumarin-marked AgNPs for different periods of time and
stained with Lyso Tracker Red (lysosome) and DAPI (nucleus) under fluorescent microscope
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Determination of ROS Generation
The intracellular ROS generation by AgNP-treated
HePG-2 cells were detected by staining cells with DCF
fluorescence as previously reported [34, 35]. Briefly, cells
were collected and suspended in PBS with DCFH-DA at
a final concentration of 10 mM at 37 °C for 30 min.
Then, the stained cells were collected and resuspended
in PBS. The ROS level was examined by detecting the
fluorescence intensity using fluorescence microscope
and microplate reader with excitation an emission wave-
lengths set at 500 and 529 nm, respectively. Experiments
were performed in triplicate.
Western Blotting Analysis
The effects of AgNPs on the expression levels of various
intracellular proteins in HePG-2 cells were detected by
Western blotting as previously reported [36, 37]. HePG-
2 cell treatments with AgNPs were incubated with lysis
buffer to obtain total cellular proteins. The protein con-
centration was examined by BCA assay. Protein (10 μg)
was subjected to each well. The membranes were incu-
bated with primary and secondary antibodies at 1:1000
dilution in 5 % non-fat milk. Protein bands were visual-
ized with using enhanced chemiluminescence detection
reagent (ECL).
Statistical Analysis
Experiments were performed and repeated at least
three times. All the data are presented as mean ± SD.
The differences between two groups were analyzed by
two-tailed Student’s t test. Difference with P < 0.05(*) or
P < 0.01(**) was considered statistically significant. One-
way analysis of variance was used in multiple group
comparisons. These analyses were carried out using
SPSS 13.0 for windows.
Results and Discussion
Preparation and Characterization of AgNPs
In this study, a simple method was used to synthesize
AgNPs; various methods were used to characterize the
product. As shown in Fig. 1a, TEM images of AgNPs,
which demonstrated that the AgNPs presented a uniform-
ity and monodisperse spherical particles, the SAED pat-
tern, and clear lattice fringes (0.2 nm) observed in HRTEM
Fig. 3 Growth inhibition AgNPs on HePG-2 Cells. a Cell viability were treated with different concentrations of AgNPs for 72 h and measured by
MTT assay. b Morphological changes in HePG-2 cells. Bars with different characters are statistically different at P < 0.05(*) or P < 0.01(**)
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collectively suggested that the nanoparticle possessed a
pure crystal structure. In Fig. 1b, EDX indicated the pres-
ence of Ag atoms (57 %) with Cu atom signal (43 %). The
presence of Cu comes from copper grids. The atom of Ag
indicates that silver nanoparticles were successfully pre-
pared. To examine the effects of stability and surface prop-
erties of AgNPs, we detected the size distribution and zeta
potential of AgNPs. As shown in Fig. 1c, the average par-
ticle size of AgNPs was 2 nm. Furthermore, in Fig. 1d, the
zeta potential of AgNPs was −15 mV.
Localization and Uptake Pathways of AgNPs
Endocytosis is one of the primary pathways for cellular uptake
of nanoparticles [38]. To examine the intracellular transloca-
tion of the nanoparticles, the localization of AgNPs in HePG-
2 cells was tracked by simultaneous staining of cell nucleus.
As shown in Fig. 2, the co-localization of AgNPs and
lysosomes was found accumulated in HePG-2 cell mem-
brane and gradually enhanced after then. AgNPs escaped
from lysosome after 60 min, transported into the cytosol,
and distributed in cells after 120 min. This result dem-
onstrates that lysosome is the target organelle of AgNPs.
In Vitro Anticancer Activity of AgNPs
The cytotoxic effect of AgNPs on HePG-2 cells was eval-
uated by MTT assay. As shown in Fig. 3a, the AgNPs
significantly inhibited the growth of HePG-2 cells in a
dose-dependent manner.
HePG-2 cells treated with 5 μg/ml AgNPs for 72 h re-
duced cell viability to 95 %. At the concentrations of 10
and 20 μg/ml, AgNPs decreased the cell viability to 83
and 49 %, respectively. The anticancer activity effects of
AgNPs were also further confirmed as shown in Fig. 3b.
Cell treated with AgNPs showed cytoplasm shrinkage
and loss of cell-to-cell contact. Taken together, these re-
sults indicated that AgNPs inhibited cancer cell growth
in a dose-dependent manner.
Induction of Cell Apoptosis by AgNPs
Apoptosis plays an essential role in a wide variety of
different biological systems, including normal cell cycle,
the immune system, embryonic development, morpho-
logic change, and chemical-induced cell death [39]. There-
fore, flow cytometry was used to investigate whether
apoptosis was involved in cell death by AgNPs. The
apoptotic cells which have DNA fragmentation show a
typical sub-G1 peak in DNA histogram. As shown in
Fig. 4a, b, 5 μg/ml of AgNPs increased the percentage
of apoptotic cells to 8.62 %. However, the sub-G1 apop-
totic cell population was significantly increased in a
dose-dependent manner. At concentrations of 10 and
20 μg/ml, AgNPs increased the apoptotic cells to 19.83
Fig. 4 Flow cytometric analysis of HePG-2 cells after treated with AgNPs for 72 h stained with PI after fixation by 70 % ethanol. As shown in a and b, the
cell cycle distribution after different treatments and apoptotic cell population was determined by PI flow cytometric analysis. Bars with different characters
are statistically different at P< 0.05(*) or P< 0.01(**)
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and 25.11 %, respectively. The results indicated that
AgNPs depressed HePG-2 cells proliferation.
Induction of ROS Generation by AgNPs
ROS has been regarded as a critical activator of cell
apoptosis, especially that induced by anticancer drugs
[40]. Therefore, in this study, the ROS generation was
determined by DCF fluorescence assay to reveal its
role the action mechanisms of AgNPs. As shown in
Fig. 5a, b, AgNPs gradually increased the intracellular
ROS generation in HePG-2 cells; the stronger fluores-
cent intensity of DCF was found in HePG-2 cells at the
concentration 20 μg/ml. As shown in Fig. 5c, AgNPs in-
creased the intracellular ROS generation to 153, 229, and
290 % at concentration of 5, 10, and 20 μg/ml, respect-
ively. The dates indicate that the involvement of ROS may
play an important role in the anticancer action.
Activation of ROS-Mediated Signaling Pathways by AgNPs
Intracellular ROS overproduction could trigger DNA
damage and cell apoptosis by activating of AKT, MAPKs,
and p53 signaling pathways. The effects on the ROS-
mediated downstream pathways were examined by using
Western blotting. As shown in Fig. 6a, treatments of cells
with AgNPs significantly increased the expression levels of
p53. Meanwhile, as a biochemical marker of DNA dam-
age, H2X was significantly activated by AgNPs. Moreover,
as shown in Fig. 6b, AgNP treatment triggered differential
effects on JNK, ERK, and p38. AgNPs significantly inhib-
ited total ERK and increased the JNK and p38. Meanwhile,
treatment of the cells with AgNPs effectively suppressed
the expression levels of total AKT in HePG-2 cells as
shown in Fig. 6d. The caspase family exhibits important
functions in the regulation process of cell apoptosis.
Caspase-3 acts as a central regulator in the signaling net-
work [41]. Therefore, the cleavage of caspase-3 and PARP
Fig. 5 ROS overproduction induced by AgNPs. a–c Changes of intracellular ROS generation. ROS levels were detected by DCF fluorescence intensity.
Bars with different characters are statistically different at P < 0.05(*) or P < 0.01(**)
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was examined to evaluate their involvement and contribu-
tion to cell apoptosis. As shown in Fig. 6c, AgNPs signifi-
cantly enhanced the activation of caspase-3 and the
cleavage of downstream effect PARP. Taken together,
these results support that AgNPs induce HePG-2 cells
apoptosis by regulation of ROS-mediated AKT, MAPKs,
and p53 signaling pathways.
Conclusions
In summary, a simple chemical method under redox sys-
tem for preparation of silver nanoparticles has been de-
scribed in this study. AgNPs exhibit greater abilities to
inhibit HePG-2 cells proliferation and enhanced cellular
uptake at the average size of 2 nm. AgNPs with dose-
dependent manner significantly increased the apoptotic cell
population (sub-G1). The studies on the underlying mo-
lecular mechanisms revealed that the major mode of cell
death induced by AgNPs was cell apoptosis. The mecha-
nisms indicated that AgNPs promote caspase-3-mediated
apoptosis by the involvement of ROS generation. Further
investigations on apoptotic signaling pathway triggered by
the AgNPs in HePG-2 cells are p53, AKT, and MAPKs
pathways. Taken together, our findings suggest that AgNP
is a prospect silver species with anticancer properties.
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